Table 1 In vivo study design and LV-PUR/ceramic composite characteristics
Treatment group | Ceramic component | Particle diameter (μm) | Ceramic composition (wt%) | Number |
|---|---|---|---|---|
LV/BG | Bioglass (45S5) | 150–212 | 45 | 3 |
LV/CM | 85/15 β-tricalcium phosphate/hydroxyapatite ceramic | 100–500 | 45 | 3 |